CAMTEK LTD (CAMT) Market Cap & Valuation Ratios
CAMTEK LTD (CAMT) has a market cap of $5.6B, a trailing P/E of 116.5 and a price-to-sales ratio of 10.2, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-09-30 · read by EquiReason
CAMTCAMTEK LTDFollow CAMT — free
—
Price chart with a free account
- Market cap
- 5.6B
- Annual P/E
- 116.5
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Peers
scientific & technical instruments · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| CAMT | 5.6 | 116.5 | 10.7 | 41.5 | 2.3% | +12% | 26% | 13% |
| MKSI | 13 | 31.3 | 3.9 | 16.4 | 3.4% | +16% | 16% | 9% |
| NVMI | 9.9 | 39.1 | 10.8 | 36.6 | 2.2% | +16% | 29% | 12% |
| CGNX | 9.3 | 53.4 | 8.2 | 33.4 | 2.9% | +17% | 22% | 12% |
| ESE | 6.0 | — | 4.7 | 24.6 | 3.3% | +27% | 16% | 8% |
| ST | 5.9 | 67.3 | 2.1 | 15.1 | 9.9% | +0.8% | 8% | 3% |
| NOVT | 5.3 | 89.7 | 4.7 | 31.4 | 2.1% | +8% | 9% | 6% |
| VNT | 4.6 | 14.2 | 2.0 | 10.0 | 8.3% | +0.9% | 19% | 16% |
| BMI | 4.3 | 34.9 | 4.8 | 20.9 | 3.3% | -2% | 19% | 23% |
| ITRI | 3.8 | 14.7 | 2.0 | 12.7 | 10.0% | -6% | 13% | 13% |
| ALMR | 2.1 | — | — | — | — | — | -46% | — |
| Median of these 10 | 37.0 | 4.7 | 20.9 | 3.3% | +8% | 16% | 12% |
P/E 116.5 vs. a peer median of 37.0; EV/Sales 10.7 vs. 4.7. CAMT's own P/E sits at the 82nd percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesESE and ALMR have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
CAMTEK LTD — questions
- What is CAMTEK LTD's market cap?
- $5.6B.
- What is CAMTEK LTD's P/E ratio?
- 116.5 on trailing twelve-month earnings to 2026-09-30.
- What is CAMTEK LTD's price-to-sales ratio?
- 10.2.
Every figure on this page comes from CAMTEK LTD's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.